Skip to main content

Oaktree Acquisition Corp. III Life Sciences

For the period ended Sep 30, 2025. Filed Nov 13, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 13, 2025

OACC$10.70-0.2%Stored close · as of Nov 5, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

Page
Part I. Financial Information1
Item 1. Interim Financial Statements1
Condensed Balance Sheets as of September 30, 2025 (Unaudited) and December 31, 20241
Condensed Statements of Operations for the three and nine months ended September 30, 2025, for the three months ended September 30, 2024 and for the period from June 28, 2024 (Inception) through September 30, 2024 (Unaudited)2
Condensed Statements of Changes in Shareholders’ Deficit for the three and nine months ended September 30, 2025, for the three months ended September 30, 2024 and for the period from June 28, 2024 (Inception) through September 30, 2024 (Unaudited)3
Condensed Statements of Cash Flows for the nine months ended September 30, 2025 and for the period from June 28, 2024 (Inception) through September 30, 2024 (Unaudited)4
Notes to Condensed Financial Statements (Unaudited)5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations16
Item 3. Quantitative and Qualitative Disclosures About Market Risk19
Item 4. Controls and Procedures19
Part II. Other Information20
Item 1. Legal Proceedings20
Item 1A. Risk Factors20
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds20
Item 3. Defaults Upon Senior Securities20
Item 4. Mine Safety Disclosures20
Item 5. Other Information20
Item 6. Exhibits20
Part III. Signatures22
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.